Corrigendum to "Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells" [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549-562] No … ← Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis Developmental dysfunction in a preclinical model of Kcnq2 developmental and epileptic encephalopathy →